Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Jun;44(6):1556-61.
doi: 10.1128/AAC.44.6.1556-1561.2000.

OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain

Affiliations

OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain

G Bou et al. Antimicrob Agents Chemother. 2000 Jun.

Erratum in

  • Antimicrob Agents Chemother. 2006 Jun;50(6):2280

Abstract

Acinetobacter baumannii RYC 52763/97, a clinical isolate involved in a prolonged nosocomial outbreak at our hospital, was resistant to all beta-lactams tested, including imipenem and meropenem, which had MICs of 128 and 256 microg/ml, respectively. This strain synthesized three beta-lactamases: a plasmid-mediated TEM-1 beta-lactamase (pI 5.4), an AmpC-type chromosomal cephalosporinase (pI 9.4), and a novel, presumptively chromosomally mediated OXA-related enzyme (pI 9.0) named OXA-24. After cloning and sequencing, the deduced amino acid sequence of the OXA-24 beta-lactamase showed 40% homology with the OXA-10 (PSE-2) and OXA-7 beta-lactamases, 39% homology with the OXA-11 and OXA-5 enzymes, and 33% homology with the LCR-1 beta-lactamase. The amino acid sequence of the OXA-24 beta-lactamase contained the STFK motif found in serine beta-lactamases, but the typical class D triad KTG was replaced by KSG and the motif YGN was replaced by FGN. The OXA-24 beta-lactamase hydrolyzed benzylpenicillin and cephaloridine but lacked activity against oxacillin, cloxacillin, and methicillin. The enzymatic activity was inhibited by chloride ions and by tazobactam (50% inhibitory concentration [IC(50)], 0.5 microM), sulbactam (IC(50), 40 microM), and clavulanic acid (IC(50), 50 microM). Carbapenem MICs for an Escherichia coli transformant (pBMB-1) expressing the cloned OXA-24 enzyme had a fourfold increase. Relative V(max)/K(m) values of 13 and 6 were obtained with imipenem and meropenem, respectively, and a positive microbiological assay result with imipenem was obtained with a purified enzymatic extract of this transformant strain. Therefore, we consider this new beta-lactamase to be involved in the carbapenem resistance of A. baumannii RYC 52763/97.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Nucleotide sequence of the blaOXA-24 gene. The boldface atg and taa represent the initiation and termination codons, respectively. The deduced amino acid sequence of OXA-24 is shown below the nucleotide sequence. Amino acids of the signal peptide, written in lowercase and bold letters, were identified using the Swiss-Prot annotated protein sequence database (http://www.expasy.ch/sprot/sprot-top.html/). The β-lactamase active site STFK, the typical motif FGN, and the triad KSG are indicated by bold letters. The locations of the primers used to sequence the gene are underlined.
FIG. 2
FIG. 2
Phylogram relating OXA-24 to 12 other class D β-lactamases. Analysis was performed using the CLUSTAL W multiple sequence alignment program. A gap penalty of three was applied, and 100 bootstrap replications were applied.
FIG. 3
FIG. 3
Microbiological assay plate showing inactivation of imipenem (central disk) by the A. baumannii OXA-24 enzyme. (1) Twenty microliters of semipurified OXA-24 protein (nitrocefin-specific activity, 251.5 μmol/min/μl); (2) 10 μl of the same extract; (3) 5 μl of the same extract; (4) 20 μl of phosphate-buffered saline.

References

    1. Afzal M S, Livermore D. Worldwide emergence of carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother. 1998;41:576–577. - PubMed
    1. Ambler R P. The structure of β-lactamases. Philos Trans R Soc Lond Biol Sci. 1980;289:321–331. - PubMed
    1. Amyes S G B, Young H-K. Mechanism of antibiotic resistance in Acinetobacter spp.—genetics of resistance. In: Bergogne-Berezin E, Joly-Guillou M L, Towner K J, editors. Acinetobacter: microbiology, epidemiology, infections, management, 1996. New York, N.Y: CRC Press; 1996. pp. 185–223.
    1. Bergogne-Bérézin E. Resistance of Acinetobacter spp. to antimicrobials—overview of clinical resistance patterns and therapeutic problems. In: Bergogne-Berezin E, Joly-Guillou M L, Towner K J, editors. Acinetobacter: microbiology, epidemiology, infections, management, 1996. New York, N.Y: CRC Press; 1996. pp. 133–183.
    1. Bergogne-Bérézin E, Towner K J. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9:148–165. - PMC - PubMed